Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

NNVCNANOVIRICIDES, INC.

NYSE · CIK 0001379006
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end0630
XBRL facts312

Identity from submissions API

NameNANOVIRICIDES, INC.
CIK0001379006
TickersNNVC
ExchangesNYSE
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN760674577
LEI—
Fiscal year end0630
State of incorporationDE DE
Phone(203) 668-5580
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
1 CONTROLS DRIVE
SHELTON
CT
06484
CT
Mailing address
1 CONTROLS DRIVE
SHELTON
CT
06484
CT

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

558 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 424B5 424B5 0001104659-26-129094 333-296550 261566748 33 62095
2026-11-16 10-Q 10-Q 0001104659-26-128532 001-36081 261562723 34 5639839 1 1
2026-10-21 424B5 424B5 0001104659-26-117595 333-296550 261474454 33 93952
2026-10-08 DEF 14A DEF 14A 0001104659-26-114606 001-36081 261448870 34 570545
2026-09-29 8-K FORM 8-K 5.02,9.01 0001104659-26-111952 001-36081 261424263 34 221485 1 1
2026-09-28 10-K 10-K 0001104659-26-111390 001-36081 261417718 34 8521476 1 1
2026-09-03 424B3 424B3 0001104659-26-104857 333-298493 261356534 33 108552
2026-08-31 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002837 333-298493 261348385 33 1694
2026-08-21 S-3 FORM S-3 0001104659-26-099705 333-298493 261305122 33 487744 1 1
2026-07-30 8-K FORM 8-K 1.01,8.01,9.01 0001104659-26-088393 001-36081 261219946 34 858907 1 1
2026-07-27 424B5 424B5 0001104659-26-086797 333-296550 261202776 33 655490
2026-07-27 424B5 424B5 0001104659-26-086767 333-296550 261202748 33 60471
2026-07-17 8-K FORM 8-K 1.01,9.01 0001104659-26-084668 001-36081 261184244 34 541568 1 1
2026-07-17 424B5 424B5 0001104659-26-084656 333-296550 261184097 33 397222
2026-07-01 424B3 424B3 0001104659-26-079885 333-296790 261145662 33 108627
2026-06-26 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002136 333-296790 261131107 33 1694
2026-06-23 CORRESP filename1.htm 0001104659-26-076720 6488
2026-06-22 DEL AM DEL AM 0001104659-26-076324 333-296790 261109459 33 14511
2026-06-18 UPLOAD filename1.pdf 0000000000-26-006093 333-296790 146365
2026-06-17 DEL AM DEL AM 0001104659-26-074774 333-296550 261096307 33 41110
2026-06-15 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001997 333-296550 261092791 33 1694
2026-06-15 S-3 FORM S-3 0001104659-26-074065 333-296790 261091270 33 353970
2026-06-11 CORRESP filename1.htm 0001104659-26-072869 6542
2026-06-10 UPLOAD filename1.pdf 0000000000-26-005858 333-296550 145997
2026-06-05 S-3 FORM S-3 0001104659-26-071007 333-296550 261069636 33 636700
2026-05-21 8-K FORM 8-K 7.01 0001104659-26-064754 001-36081 261005790 34 189577 1 1
2026-05-20 8-K FORM 8-K 1.01,8.01,9.01 0001104659-26-064544 001-36081 261004479 34 892212 1 1
2026-05-18 424B5 424B5 0001104659-26-063050 333-271706 26990913 33 563186
2026-05-15 10-Q 10-Q 0001104659-26-061499 001-36081 26981598 34 5944778 1 1
2026-02-25 D xslFormDX01/primary_doc.xml 06b 0001104659-26-019284 021-574544 26673590 33 9743
2026-02-17 10-Q 10-Q 0001104659-26-016476 001-36081 26642241 34 5722912 1 1
2025-12-30 424B3 424B3 0001104659-25-125250 333-292142 251614664 33 98363
2025-12-19 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003874 333-292142 251589139 33 1694
2025-12-18 CORRESP filename1.htm 0001104659-25-122405 17765
2025-12-16 DEL AM DEL AM 0001104659-25-121604 333-292142 251575740 33 14870
2025-12-15 S-3 FORM S-3 0001104659-25-121169 333-292142 251571944 33 338185 1 1
2025-11-26 8-K FORM 8-K 5.07 0001104659-25-116457 001-36081 251530806 34 195607 1 1
2025-11-14 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001104659-25-112644 001-36081 251487378 34 1142005 1 1
2025-11-14 10-Q 10-Q 0001104659-25-112608 001-36081 251487221 34 5048315 1 1
2025-11-12 424B5 424B5 0001104659-25-110251 333-271706 251471948 33 483685
2025-11-12 424B5 424B5 0001104659-25-110054 333-271706 251470810 33 25970
2025-10-08 DEF 14A DEF 14A 0001104659-25-097618 001-36081 251380993 34 579392
2025-10-01 8-K FORM 8-K 5.02,9.01 0001104659-25-095676 001-36081 251365463 34 409190 1 1
2025-09-29 10-K 10-K 0001104659-25-094527 001-36081 251356620 34 7339598 1 1
2025-05-15 10-Q 10-Q 0001410578-25-001336 001-36081 25954165 34 5658772 1 1
2025-02-14 10-Q 10-Q 0001410578-25-000140 001-36081 25629653 34 5663771 1 1
2025-01-28 4 PRIMARY DOCUMENT 0002052587-25-000003 16064
2024-12-12 8-K FORM 8-K 5.07 0001104659-24-128066 001-36081 241545723 34 206239 1 1
2024-11-14 10-Q 10-Q 0001410578-24-001991 001-36081 241463130 34 5042788 1 1
2024-10-15 DEF 14A DEF 14A 0001104659-24-108620 001-36081 241372377 34 771987
2024-09-27 10-K 10-K 0001410578-24-001650 001-36081 241335066 34 7816258 1 1
2024-08-09 8-K FORM 8-K 5.02,9.01 0001104659-24-087828 001-36081 241193270 34 232098 1 1
2024-08-09 424B5 424B5 0001104659-24-087776 333-271706 241192546 33 21966
2024-05-15 10-Q 10-Q 0001410578-24-000843 001-36081 24946688 34 5525016 1 1
2024-05-13 UPLOAD filename1.pdf 0000000000-24-005448 001-36081 39502
2024-05-08 CORRESP filename1.htm 0001104659-24-058925 24088
2024-04-22 UPLOAD filename1.pdf 0000000000-24-004397 001-36081 43003
2024-04-09 CORRESP filename1.htm 0001104659-24-045423 79969
2024-04-05 8-K FORM 8-K 1.01,9.01 0001104659-24-044367 001-36081 24827553 34 515072 1 1
2024-04-05 424B5 424B5 0001104659-24-044352 333-271706 24827368 33 15696
2024-02-16 8-K FORM 8-K 1.01,9.01 0001104659-24-024973 001-36081 24649171 34 491961 1 1
2024-02-14 10-Q 10-Q 0001410578-24-000048 001-36081 24639916 34 5253974 1 1
2024-02-13 UPLOAD filename1.pdf 0000000000-24-001724 001-36081 50258
2024-01-19 8-K FORM 8-K 5.07 0001104659-24-005254 001-36081 24546171 34 205923 1 1
2023-12-04 DEF 14A DEF 14A 0001104659-23-123215 001-36081 231463083 34 255850
2023-11-14 10-Q 10-Q 0001410578-23-002484 001-36081 231407087 34 4658471 1 1
2023-11-07 8-K FORM 8-K 8.01,9.01 0001104659-23-114862 001-36081 231381064 34 199613 1 1
2023-10-13 10-K 10-K 0001410578-23-002146 001-36081 231325360 34 7021922 1 1
2023-09-28 NT 10-K NT 10-K 0001104659-23-104786 001-36081 231290396 34 21283
2023-09-01 8-K FORM 8-K 1.01,2.03,9.01 0001104659-23-097802 001-36081 231233160 34 283116 1 1
2023-08-07 424B5 424B5 0001104659-23-087933 333-271706 231145169 33 440641
2023-05-25 8-K FORM 8-K 8.01,9.01 0001104659-23-064652 001-36081 23961219 34 234572 1 1
2023-05-22 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-05-22 13:00:00 9999999995-23-001499 333-271706 23946425 33 1651
2023-05-17 CORRESP filename1.htm 0001104659-23-061768 23059
2023-05-15 10-Q 10-Q 0001410578-23-001235 001-36081 23923348 34 4766153 1 1
2023-05-12 UPLOAD filename1.pdf 0000000000-23-005084 40131
2023-05-08 S-3/A FORM S-3/A 0001104659-23-057263 333-271706 23898964 33 65547
2023-05-05 S-3 FORM S-3 0001104659-23-056545 333-271706 23895154 33 761280
2023-03-31 8-K FORM 8-K 1.01,9.01 0001104659-23-040296 001-36081 23789184 34 259753 1 1
2023-02-14 10-Q 10-Q 0001410578-23-000129 001-36081 23631204 34 4332005 1 1
2023-02-13 8-K FORM 8-K 5.07 0001104659-23-019813 001-36081 23619591 34 197556 1 1
2022-12-23 DEFA14A DEFA14A 0001104659-22-129634 001-36081 221483097 34 16965
2022-12-22 8-K FORM 8-K 5.07,8.01 0001104659-22-129595 001-36081 221482729 34 209752 1 1
2022-11-15 DEF 14A DEF 14A 0001104659-22-119151 001-36081 221391581 34 436247
2022-11-14 10-Q 10-Q 0001410578-22-003398 001-36081 221386823 34 4247203 1 1
2022-11-04 PRE 14A PRE 14A 0001104659-22-114925 001-36081 221362739 34 436194
2022-10-13 10-K 10-K 0001410578-22-002878 001-36081 221309664 34 8837745 1 1
2022-10-11 8-K FORM 8-K 5.02,9.01 0001104659-22-107752 001-36081 221304408 34 221082 1 1
2022-09-29 NT 10-K NT 10-K 0001104659-22-104045 001-36081 221279124 34 20670
2022-08-10 4 FORM 4 0001140361-22-029132 4963
2022-05-16 10-Q 10-Q 0001410578-22-001688 001-36081 22929996 34 5707966 1 1
2022-02-14 10-Q 10-Q 0001410578-22-000141 001-36081 22632981 34 5407836 1 1
2021-11-26 8-K FORM 8-K 5.07 0001104659-21-143985 001-36081 211452052 34 204050 1 1
2021-11-15 10-Q FORM 10-Q 0001104659-21-139231 001-36081 211411425 34 4923831 1 1
2021-10-12 10-K FORM 10-K 0001104659-21-125343 001-36081 211318914 34 8670102 1
2021-10-12 DEF 14A DEF 14A 0001104659-21-124918 001-36081 211316712 34 1212327
2021-09-28 NT 10-K NT 10-K 0001104659-21-120260 001-36081 211287361 34 23353
2021-09-21 8-K FORM 8-K 7.01,8.01,9.01 0001104659-21-117728 001-36081 211265311 34 32487
2021-09-15 8-K FORM 8-K 1.01,5.02,9.01 0001104659-21-115943 001-36081 211255734 34 182082
2021-05-14 10-Q FORM 10-Q 0001104659-21-066909 001-36081 21925208 34 4734972 1
2021-02-16 10-Q FORM 10-Q 0001104659-21-024154 001-36081 21639302 34 4394311 1
2021-02-16 SC 13G/A SC 13G/A 0001104659-21-023203 005-90672 21633584 34 58261
2021-02-12 SC 13G/A AMENDMENT TO FORM SC 13G 0001387131-21-002134 005-90672 21621800 34 103774
2021-01-26 SC 13G/A NANOVIRICIDES, INC. 0000902664-21-000519 005-90672 21552251 34 72997
2021-01-04 SC 13G/A SABBY 13G-A NNVC 1.04.21 0001535610-21-000004 005-90672 21500685 34 12941
2020-12-10 8-K FORM 8-K 5.07 0001104659-20-134212 001-36081 201380946 34 28481
2020-12-03 424B5 424B5 0001104659-20-132019 333-237370 201367276 33 23189
2020-11-19 8-K FORM 8-K 5.02,9.01 0001104659-20-127395 001-36081 201329383 34 228561
2020-11-16 10-Q FORM 10-Q 0001104659-20-125844 001-36081 201317530 34 4008604 1
2020-10-26 DEF 14A DEF 14A 0001104659-20-118177 001-36081 201260972 34 526671
2020-10-13 10-K FORM 10-K 0001104659-20-114577 001-36081 201237403 34 9564542 1
2020-09-28 NT 10-K NT 10-K 0001104659-20-109325 001-36081 201204733 34 22782
2020-09-04 8-K FORM 8-K 7.01,9.01 0001104659-20-102620 001-36081 201161945 34 38443
2020-08-03 8-K FORM 8-K 1.01,9.01 0001104659-20-089704 001-36081 201070124 34 282632
2020-07-31 424B5 424B5 0001104659-20-089188 333-237370 201067040 33 1062397
2020-07-20 SC 13G ACQUISITION OF BENEFICIAL OWNERSHIP 0001387131-20-006537 005-90672 201036377 34 128538
2020-07-13 8-K FORM 8-K 1.01,8.01,9.01 0001104659-20-083121 001-36081 201025666 34 354388
2020-07-09 424B5 424B5 0001104659-20-082422 333-237370 201021114 33 1090512
2020-07-09 424B5 424B5 0001104659-20-082204 333-237370 201019439 33 1088013
2020-06-22 10-Q FORM 10-Q 0001104659-20-075651 001-36081 20979179 34 5813672 1
2020-06-04 8-K FORM 8-K 5.02 0001104659-20-069859 001-36081 20943494 34 14550
2020-05-29 SC 13G SC 13G 0001104659-20-067429 005-90672 20924720 34 96899
2020-05-22 8-K FORM 8-K 1.01,8.01,9.01 0001104659-20-065358 001-36081 20905932 34 328270
2020-05-22 424B5 424B5 0001104659-20-064991 333-237370 20903471 33 1012382
2020-05-19 8-K FORM 8-K 5.02,9.01 0001104659-20-063847 001-36081 20894685 34 224233
2020-05-14 8-K 8-K 8.01 0001104659-20-061689 001-36081 20878687 34 28150
2020-05-01 3 OWNERSHIP DOCUMENT 0001104659-20-055415 2832
2020-04-02 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2020-04-02 16:00:00 9999999995-20-000674 333-237370 20771558 33 1674
2020-03-31 CORRESP filename1.htm 0001104659-20-040898 29438
2020-03-26 UPLOAD filename1.pdf 0000000000-20-002654 45840
2020-03-24 S-3 FORM S-3 0001104659-20-037812 333-237370 20739097 33 1322528
2020-03-20 8-K FORM 8-K 5.03,5.07,9.01 0001104659-20-036792 001-36081 20731743 34 569436
2020-02-19 DEF 14A DEF 14A 0001104659-20-022509 001-36081 20626778 34 335448
2020-02-14 10-Q FORM 10-Q 0001104659-20-021930 001-36081 20621058 34 5052200 1
2020-02-11 8-K FORM 8-K 5.02,9.01 0001104659-20-016291 001-36081 20597021 34 205847
2020-02-05 PRE 14A PRE 14A 0001104659-20-011241 001-36081 20579015 34 107819
2020-01-28 8-K FORM 8-K 1.01,3.02,8.01,9.01 0001104659-20-007313 001-36081 20551258 34 316230
2020-01-27 8-K FORM 8-K 1.01,8.01,9.01 0001104659-20-007211 001-36081 20550588 34 266462
2020-01-27 SC 13G NANOVIRICIDES, INC. 0000902664-20-000482 005-90672 20548056 34 106473
2020-01-24 SC 13G/A SABBY 13G NNVC 1.24.20 0001535610-20-000061 005-90672 20545629 34 13125
2020-01-24 424B1 424B1 0001104659-20-006423 333-235306 20543532 33 1817546
2020-01-09 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2020-01-09 16:00:00 9999999995-20-000048 333-235306 20519334 33 1674
2020-01-09 CORRESP filename1.htm 0001104659-20-002474 8099
2020-01-08 CORRESP filename1.htm 0001104659-20-002319 13438
2020-01-08 S-1/A FORM S-1/A 0001104659-20-002298 333-235306 20516399 33 2102085
2020-01-07 S-1/A FORM S-1/A 0001104659-20-001737 333-235306 20511928 33 2098153
2020-01-02 8-K/A FORM 8-K/A 1.01,3.02,9.01 0001104659-20-000201 001-36081 20500760 34 22378
2019-12-23 S-1/A S-1/A 0001104659-19-075427 333-235306 191304575 33 2097825
2019-12-19 8-K FORM 8-K 1.01,9.01 0001104659-19-074405 001-36081 191296299 34 183731
2019-12-17 FWP FREE WRITING PROSPECTUS 0001104659-19-073169 333-235306 191288421 34 10675801
2019-12-17 S-1/A FORM S-1/A 0001104659-19-073165 333-235306 191288415 33 2067417
2019-12-13 8-K FORM 8-K 5.07,7.01,9.01 0001104659-19-072646 001-36081 191285318 34 47922
2019-12-09 UPLOAD filename1.pdf 0000000000-19-016217 45842
2019-11-29 S-1 FORM S-1 0001104659-19-068364 333-235306 191259318 33 2065912
2019-11-15 10-Q FORM 10-Q 0001104659-19-064800 001-36081 191225380 34 4032528 1
2019-11-14 NT 10-Q NT 10-Q 0001104659-19-064036 001-36081 191218730 34 21074
2019-11-06 8-K FORM 8-K 1.01,9.01 0001104659-19-060203 001-36081 191194903 34 174738
2019-11-06 RW RW 0001104659-19-060199 333-233998 191194898 NE 80152
2019-10-28 DEF 14A DEF 14A 0001104659-19-056946 001-36081 191173725 34 1705281
2019-10-16 PRE 14A PRE 14A 0001104659-19-054247 001-36081 191151875 34 267734
2019-09-27 S-1 FORM S-1 0001144204-19-046313 333-233998 191123888 33 2489675
2019-09-26 8-K FORM 8-K 5.03,9.01 0001144204-19-045967 001-36081 191115473 34 49995
2019-08-23 10-K FORM 10-K 0001144204-19-041547 001-36081 191049702 34 8843731 1
2019-08-20 3 OWNERSHIP DOCUMENT 0001144204-19-040854 2819
2019-08-01 8-K FORM 8-K 5.02,9.01 0001144204-19-037222 001-36081 19993117 34 23765
2019-06-10 8-K 8-K 5.02,9.01 0001144204-19-030343 001-36081 19887491 34 206014
2019-05-15 10-Q FORM 10-Q 0001144204-19-026612 001-36081 19828809 34 7434911 1
2019-03-08 D xslFormDX01/primary_doc.xml 06b 0001144204-19-012971 021-334409 19668942 33 9860
2019-03-01 8-K 8-K 1.01,3.02,9.01 0001144204-19-011452 001-36081 19646602 34 521644
2019-03-01 424B5 424B5 0001144204-19-011400 333-216345 19646030 33 411767
2019-02-14 10-Q FORM 10-Q 0001144204-19-008138 001-36081 19607100 34 6119615 1
2019-02-01 8-K FORM 8-K 5.02 0001144204-19-004468 001-36081 19560334 34 15959
2018-12-07 8-K FORM 8-K 5.07 0001144204-18-063617 001-36081 181223961 34 35868
2018-11-14 10-Q FORM 10-Q 0001144204-18-059983 001-36081 181184480 34 4636481 1
2018-10-31 8-K FORM 8-K 5.02,9.01 0001144204-18-056517 001-36081 181151159 34 53285
2018-10-19 DEF 14A DEFINITIVE PROXY STATEMENT 0001144204-18-054566 001-36081 181130764 34 1659462
2018-10-12 10-K 10-K 0001144204-18-053665 001-36081 181120663 34 10589494 1
2018-10-12 SC 13D d1011183sc13d.htm 0001214659-18-006490 005-90672 181118971 34 45222
2018-10-11 4 PRIMARY DOCUMENT 0001214659-18-006488 23947
2018-09-28 NT 10-K NT 10-K 0001144204-18-051597 001-36081 181095099 34 19574
2018-09-12 8-K/A FORM 8-K/A 3.01,5.02,9.01 0001144204-18-049074 001-36081 181065644 34 44918
2018-07-23 8-K FORM 8-K 1.01,5.02,9.01 0001144204-18-039366 001-36081 18964865 34 208824
2018-07-19 8-K FORM 8-K 1.01,9.01 0001144204-18-038907 001-36081 18959358 34 85069
2018-07-11 8-K FORM 8-K 3.01,5.02,9.01 0001144204-18-037894 001-36081 18947862 34 32942
2018-05-21 10-Q 10-Q 0001144204-18-030083 001-36081 18849798 34 5097963 1
2018-05-15 NT 10-Q NT 10-Q 0001144204-18-028923 001-36081 18837000 34 21124
2018-05-04 4 FORM 4 0001140361-18-021800 2834
2018-05-04 8-K FORM 8-K 1.01,3.02,5.02,9.01 0001144204-18-025443 001-36081 18808860 34 148658
2018-02-20 10-Q 10-Q 0001144204-18-009768 001-36081 18624079 34 4809824 1
2018-02-14 NT 10-Q FORM 12B-25 0001144204-18-009046 001-36081 18613699 34 21560
2017-12-15 8-K FORM 8-K 5.07 0001144204-17-063872 001-36081 171257957 34 28443
2017-11-22 424B5 424B5 0001144204-17-060674 333-216345 171220151 33 291317
2017-11-14 10-Q 10-Q 0001144204-17-059130 001-36081 171203060 34 4587071 1
2017-11-08 DEFR14A DEFR14A 0001144204-17-057336 001-36081 171187525 34 1321393
2017-10-27 DEF 14A DEF 14A 0001144204-17-054403 001-36081 171157785 34 1321432
2017-09-28 10-K 10-K 0001144204-17-050412 001-36081 171108012 34 8863164 1
2017-05-15 10-Q 10-Q 0001144204-17-027501 001-36081 17844598 34 5939232 1
2017-04-25 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2017-04-25 10:00:00 9999999995-17-000938 333-216345 17782368 33 1724
2017-04-20 CORRESP filename1.htm 0001144204-17-021300 14318
2017-04-18 CORRESP filename1.htm 0001144204-17-020914 18725
2017-04-18 S-3/A S-3/A 0001144204-17-020912 333-216345 17767456 33 708570
2017-03-15 UPLOAD filename1.pdf 0000000000-17-008636 41742
2017-03-01 S-3 FORM S-3 0001144204-17-011857 333-216345 17649677 33 731650
2017-02-14 10-Q FORM 10-Q 0001144204-17-009000 001-36081 17610797 34 6010924 1
2017-02-13 8-K FORM 8-K 1.01,3.02,9.01 0001144204-17-008029 001-36081 17600941 34 71797
2017-02-03 4 OWNERSHIP DOCUMENT 0001144204-17-005838 9140
2016-12-15 8-K FORM 8-K 5.07 0001144204-16-139764 001-36081 162054240 34 28170
2016-11-14 10-Q FORM 10-Q 0001144204-16-134199 001-36081 161995033 34 5030332 1
2016-10-28 DEF 14A DEF 14A 0001144204-16-130330 001-36081 161959504 34 719507
2016-09-16 10-K FORM 10-K 0001144204-16-124276 001-36081 161889893 34 9455037 1
2016-05-24 4 OWNERSHIP DOCUMENT 0001144204-16-104385 5465
2016-05-18 4 OWNERSHIP DOCUMENT 0001144204-16-103281 7016
2016-05-10 10-Q FORM 10-Q 0001144204-16-100445 001-36081 161636054 34 5906430 1
2016-05-05 4 OWNERSHIP DOCUMENT 0001144204-16-099213 7014
2016-05-02 4 OWNERSHIP DOCUMENT 0001144204-16-098303 5465
2016-04-14 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001144204-16-093294,2016-04-14 9999999995-16-004208 333-199757 161573061 33 1738
2016-04-07 POS AM POS AM 0001144204-16-093294 333-199757 161560699 33 32988
2016-02-24 4 OWNERSHIP DOCUMENT 0001144204-16-084125 5464
2016-02-16 4 OWNERSHIP DOCUMENT 0001144204-16-082885 13000
2016-02-09 10-Q FORM 10-Q 0001144204-16-079966 001-36081 161399732 34 5597549 1
2016-01-29 8-K 8-K 3.03,5.03,5.07 0001144204-16-077921 001-36081 161374193 34 30644
2015-12-08 DEF 14A DEF 14A 0001144204-15-069795 001-36081 151274329 34 2643300
2015-11-17 4 OWNERSHIP DOCUMENT 0001144204-15-066271 5585
2015-11-09 10-Q FORM 10-Q 0001144204-15-063679 001-36081 151215294 34 5126024 1
2015-10-23 4 OWNERSHIP DOCUMENT 0001144204-15-060613 10634
2015-09-24 4 FORM 4 0001140361-15-035881 10130
2015-09-24 4 FORM 4 0001140361-15-035878 9950
2015-09-15 4 OWNERSHIP DOCUMENT 0001144204-15-055102 5585
2015-09-14 10-K FORM 10-K 0001144204-15-054864 001-36081 151105911 34 8292498 1
2015-08-27 4 OWNERSHIP DOCUMENT 0001144204-15-052403 5482
2015-08-25 4 OWNERSHIP DOCUMENT 0001144204-15-051838 14720
2015-07-24 8-K FORM 8-K 5.02 0001144204-15-044157 001-36081 151005356 34 16724
2015-07-10 4 OWNERSHIP DOCUMENT 0001144204-15-042096 5586
2015-06-25 4 OWNERSHIP DOCUMENT 0001144204-15-039151 7002
2015-06-18 4 OWNERSHIP DOCUMENT 0001144204-15-037879 7000
2015-05-21 4 OWNERSHIP DOCUMENT 0001144204-15-032895 7001
2015-05-15 10-Q FORM 10-Q 0001144204-15-031364 001-36081 15867916 34 9045988 1
2015-05-12 4 OWNERSHIP DOCUMENT 0001144204-15-029852 10035
2015-05-12 NT 10-Q NOTIFICATION OF LATE FILING 0001144204-15-029787 001-36081 15855269 34 21945
2015-03-06 424B3 PROSPECTUS SUPPLEMENT 0001144204-15-014575 333-199757 15682010 33 431633
2015-02-25 10-Q/A FORM 10-Q/A 0001144204-15-011875 001-36081 15647529 34 9410486 1
2015-02-24 10-Q FORM 10-Q 0001144204-15-011553 001-36081 15641820 34 990354
2015-02-23 10-Q/A FORM 10-Q/A 0001144204-15-011471 001-36081 15640638 34 13920934 1
2015-02-23 10-K/A FORM 10-K/A 0001144204-15-011466 001-36081 15640580 34 20702651 1
2015-02-18 8-K FORM 8-K 4.02 0001144204-15-010712 001-36081 15628996 34 17483
2015-02-17 NT 10-Q NOTIFICATION OF LATE FILING 0001144204-15-010039 001-36081 15622176 34 17873
2015-01-26 8-K CURRENT REPORT 5.07,7.01 0001144204-15-003717 001-36081 15548093 34 25084
2015-01-13 4 FORM 4 0001140361-15-001670 11067
2015-01-12 4 FORM 4 0001140361-15-001488 8143
2015-01-09 4/A OWNERSHIP DOCUMENT 0001144204-15-001649 5691
2015-01-08 4 OWNERSHIP DOCUMENT 0001144204-15-001441 5370
2015-01-07 8-K FORM 8-K 1.01,2.01,9.01 0001144204-15-001176 001-36081 15514245 34 145740
2014-12-23 4 OWNERSHIP DOCUMENT 0001144204-14-075608 5372
2014-12-10 424B3 424B3 0001144204-14-073177 333-199757 141278333 33 428399
2014-12-09 4 OWNERSHIP DOCUMENT 0001144204-14-073035 8454
2014-12-05 DEF 14A DEFINITIVE PROXY STATEMENT 0001144204-14-072434 001-36081 141267577 34 305068
2014-12-03 8-K FORM 8-K 4.01,9.01 0001144204-14-071975 001-36081 141262430 34 19737
2014-11-17 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2014-11-17 10:00:00 9999999995-14-003378 333-199757 141229437 33 1725
2014-11-17 PRE 14A PRELIMINARY PROXY STATEMENT 0001144204-14-069264 001-36081 141228482 34 338620
2014-11-14 10-Q QUARTERLY REPORT 0001144204-14-068843 001-36081 141224691 34 6044333 1
2014-11-13 CORRESP filename1.htm 0001144204-14-067817 17731
2014-11-12 4 OWNERSHIP DOCUMENT 0001144204-14-067309 7462
2014-11-07 CORRESP filename1.htm 0001144204-14-066102 17644
2014-11-07 S-3/A AMENDMENT TO FORM S-3 0001144204-14-066101 333-199757 141205282 33 236210
2014-11-06 UPLOAD filename1.pdf 0000000000-14-055479 156757
2014-10-31 S-3 S-3 0001144204-14-064376 333-199757 141187160 33 712414
2014-10-20 4 OWNERSHIP DOCUMENT 0001144204-14-062005 14737
2014-09-30 10-K/A 10-K/A 0001144204-14-058575 001-36081 141128846 34 12884864 1
2014-09-29 NT 10-K NOTIFICATION OF LATE FILING 0001144204-14-058473 001-36081 141127804 34 22509
2014-09-29 10-K FORM 10-K 0001144204-14-058463 001-36081 141127742 34 2742817
2014-09-08 4 OWNERSHIP DOCUMENT 0001144204-14-054903 7478
2014-09-08 3/A OWNERSHIP DOCUMENT 0001144204-14-054901 7799
2014-09-08 4 FORM 4 0001140361-14-035027 7479
2014-09-05 8-K FORM 8-K 8.01 0001144204-14-054603 001-36081 141086747 34 14704
2014-08-01 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2014-08-01 13:00:00 9999999995-14-002371 333-197486 141011353 33 1725
2014-07-18 4 OWNERSHIP DOCUMENT 0001144204-14-043783 12357
2014-07-17 S-3 REGISTRATION STATEMENT 0001144204-14-043584 333-197486 14980999 33 207958
2014-07-09 8-K CURRENT REPORT 1.01,2.03,3.02,9.01 0001144204-14-041983 001-36081 14966128 34 33324
2014-06-25 8-K CURRENT REPORT 3.03 0001144204-14-039389 001-36081 14938387 34 14717
2014-06-02 8-K CURRENT REPORT 7.01,9.01 0001144204-14-035104 001-36081 14885110 34 3270555
2014-05-15 10-Q 10-Q 0001144204-14-031119 001-36081 14846482 34 17703268 1
2014-03-19 8-K/A FORM 8-K/A 3.03 0001144204-14-016697 001-36081 14704479 34 15294
2014-02-28 8-K FORM 8-K 3.03 0001144204-14-012587 001-36081 14656410 34 14497
2014-02-26 8-K CURRENT REPORT 8.01,9.01 0001144204-14-011798 001-36081 14645861 34 24807
2014-02-24 4 FORM 4 0001140361-14-009355 13597
2014-02-14 10-Q FORM 10-Q 0001144204-14-009813 001-36081 14616648 34 14324600 1
2014-01-24 8-K FORM 8-K 1.01,9.01 0001144204-14-004001 001-36081 14546845 34 430541
2014-01-23 424B5 424B5 0001144204-14-003615 333-184626 14542809 33 434507
2014-01-21 S-3MEF REGISTRATION STATEMENT 0001144204-14-002948 333-193439 14536718 33 83668
2013-12-13 8-K FORM 8-K 5.07,7.01,9.01 0001144204-13-067179 001-36081 131276398 34 45644
2013-11-18 10-Q/A AMENDMENT NO. 1 TO FORM 10-Q 0001144204-13-062836 001-36081 131227791 34 9790922 1
2013-11-14 NT 10-Q FORM 12B-25 0001144204-13-061942 001-36081 131220772 34 16073
2013-11-14 10-Q FORM 10-Q 0001144204-13-061915 001-36081 131220597 34 3546410
2013-10-23 4 FORM 4 0001140361-13-039407 5129
2013-10-22 DEF 14A DEF 14A 0001144204-13-056291 001-36081 131164016 34 365065
2013-10-08 10-K/A AMENDMENT NO.1 0001144204-13-054370 001-36081 131140487 34 18229324 1
2013-09-30 NT 10-K NOTIFICATION OF LATE FILING 0001144204-13-053093 001-36081 131123546 34 18879
2013-09-30 10-K ANNUAL REPORT 0001144204-13-053084 001-36081 131123417 34 3893313
2013-09-23 CERTNYS AUTO-GENERATED PAPER DOCUMENT 9999999997-13-014648 001-36081 13003476 34 1336
2013-09-23 8-A12B FORM 8-A12B 0001144204-13-051878 001-36081 131108997 34 26313
2013-09-16 4 OWNERSHIP DOCUMENT 0001144204-13-051071 11588
2013-09-13 8-K FORM 8-K 1.01,9.01 0001144204-13-050768 000-52318 131096970 34 448076
2013-09-12 424B5 RULE 424(B)(5) 0001144204-13-050372 333-184626 131092857 33 397350
2013-09-09 8-K FORM 8-K 5.03,9.01 0001144204-13-049761 000-52318 131085319 34 48914
2013-07-19 8-K FORM 8-K 7.01,9.01 0001144204-13-040353 000-52318 13977741 34 27567
2013-07-18 8-K CURRENT REPORT 7.01 0001144204-13-040161 000-52318 13975429 34 13991
2013-07-08 8-K FORM 8-K 7.01,9.01 0001144204-13-038606 000-52318 13958182 34 23668
2013-07-02 3 OWNERSHIP DOCUMENT 0001144204-13-037893 10121
2013-07-02 3 OWNERSHIP DOCUMENT 0001144204-13-037890 2930
2013-07-02 3 OWNERSHIP DOCUMENT 0001144204-13-037878 6937
2013-06-27 8-K CURRENT REPORT 5.02 0001144204-13-036961 000-52318 13938042 34 13992
2013-05-31 8-K CURRENT REPORT 5.02 0001144204-13-032622 000-52318 13885559 34 15545
2013-05-20 10-Q/A AMENDMENT TO FORM 10-Q 0001144204-13-030526 000-52318 13858650 34 10952795 1
2013-05-15 10-Q QUARTERLY REPORT 0001144204-13-029691 000-52318 13848565 34 2962634
2013-03-11 4 FORM 4 0001140361-13-011894 4728
2013-03-05 4/A FORM 4/A 0001140361-13-010624 4893
2013-03-05 4/A FORM 4/A 0001140361-13-010618 6358
2013-03-05 4 FORM 4 0001140361-13-010531 4815
2013-03-04 4 FORM 4 0001140361-13-010354 6279
2013-02-28 8-K CURRENT REPORT 1.01,1.02,9.01 0001144204-13-011682 000-52318 13648666 34 27536
2013-02-22 10-Q/A FORM 10-Q/A 0001144204-13-010726 000-52318 13634356 34 5881989 1
2013-02-14 10-Q FORM 10-Q 0001144204-13-009225 000-52318 13614823 34 1448394
2013-02-04 D xslFormDX01/primary_doc.xml 06 0001144204-13-005859 021-191316 13571117 33 7588
2013-02-01 8-K CURRENT REPORT 1.01,3.02 0001144204-13-005490 000-52318 13567581 34 18904
2013-02-01 4 FORM 4 0001140361-13-004245 4916
2012-12-27 8-K CURRENT REPORT 1.01,9.01 0001144204-12-069866 000-52318 121287857 34 55923
2012-12-27 424B5 PROSPECTUS SUPPLEMENT 0001144204-12-069776 333-184626 121287086 33 374912
2012-12-21 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2012-12-21 15:00:00 9999999995-12-003616 333-184626 121283524 33 1725
2012-12-20 CORRESP filename1.htm 0001144204-12-068957 26680
2012-12-20 CORRESP filename1.htm 0001144204-12-068938 26081
2012-12-04 DEF 14A DEF 14A 0001144204-12-066356 000-52318 121241490 34 773346
2012-12-03 S-3/A AMENDMENT TO S-3 0001144204-12-066124 333-184626 121238240 33 703093
2012-11-19 10-Q FORM 10-Q 0001144204-12-063924 000-52318 121215357 34 10166797 1
2012-11-14 NT 10-Q FORM 12B-25 0001144204-12-062598 000-52318 121204929 34 16424
2012-11-05 UPLOAD filename1.pdf 0000000000-12-060565 155087
2012-10-26 S-3 FORM S-3 0001144204-12-058104 333-184626 121165268 33 234823
2012-10-26 10-K/A FORM 10-K/A 0001144204-12-058049 000-52318 121164702 34 11381980 1
2012-10-15 10-K FORM 10-K 0001144204-12-056152 000-52318 121144075 34 2818882
2012-09-28 NT 10-K NOTICE UNDER RULE 12B25 0001144204-12-053690 000-52318 121117122 34 17644
2012-07-10 UPLOAD filename1.pdf 0000000000-12-035908 36341
2012-07-02 8-K/A AMENDMENT TO FORM 8-K 1.01,9.01 0001144204-12-037466 000-52318 12937065 34 371037
2012-06-29 8-K 8-K CURRENT REPORT 1.01,9.01 0001144204-12-037453 000-52318 12936914 34 207835
2012-06-28 424B5 424B5 0001144204-12-036841 333-165221 12931487 33 516810
2012-06-14 10-Q/A AMENDMENT TO FORM 10-Q 0001144204-12-034843 000-52318 12907394 34 38853
2012-06-14 10-Q/A AMENDMENT TO FORM 10-Q 0001144204-12-034812 000-52318 12907187 34 39334
2012-06-14 10-K/A AMENDMENT TO FORM 10-K 0001144204-12-034803 000-52318 12907136 34 49350
2012-06-11 CORRESP filename1.htm 0001144204-12-034313 45365
2012-05-30 CORRESP filename1.htm 0001144204-12-032614 12161
2012-05-21 10-Q QUARTERLY REPORT 0001144204-12-030837 000-52318 12857364 34 8828641 1
2012-05-15 NT 10-Q NOTIFICATION OF LATE FILING 0001144204-12-029684 000-52318 12846139 34 17337
2012-04-26 CORRESP filename1.htm 0001144204-12-024113 34251
2012-04-10 CORRESP filename1.htm 0001144204-12-020870 13742
2012-03-29 UPLOAD filename1.pdf 0000000000-12-016146 58243
2012-02-14 10-Q FORM 10-Q 0001144204-12-008747 000-52318 12609767 34 8157188 1
2012-02-09 8-K CURRENT REPORT 8.01,9.01 0001144204-12-006860 000-52318 12586155 34 40083
2012-02-08 424B3 PROSPECTUS 0001144204-12-006529 333-165221 12580442 33 13460
2011-12-12 10-Q/A AMENDMENT TO FORM 10-Q 0001144204-11-069272 000-52318 111254318 34 6598552 1
2011-11-14 10-Q FORM 10-Q 0001144204-11-064327 000-52318 111202495 34 3777016
2011-11-03 8-K NANOVIRICIDES, INC, 8-K 11-1-2011 1.01,9.01 0001140361-11-051573 000-52318 111177050 34 366877
2011-11-01 424B5 NANOVIRICIDES,INC 424B5 11-1-2011 0001140361-11-051065 333-165221 111169876 33 1470881
2011-10-20 10-K/A NANOVIRICIDES, INC 10-K/A 6-30-2011 0001140361-11-049904 000-52318 111149079 34 6017415
2011-10-18 8-K NANOVIRICIDES 8-K 10-17-2011 7.01 0001140361-11-049699 000-52318 111144813 34 20363
2011-10-17 4 FORM 4 0001140361-11-049684 6114
2011-10-14 4 FORM 4 0001140361-11-049566 6114
2011-10-13 10-K NANOVIRICIDES INC 10-K 6-30-2011 0001140361-11-049401 000-52318 111140106 34 5999558
2011-10-12 4 FORM 4 0001140361-11-049256 6109
2011-10-11 4 FORM 4 0001140361-11-048974 6114
2011-10-06 4 FORM 4 0001140361-11-048726 6113
2011-09-28 NT 10-K NONE 0001140361-11-047097 000-52318 111110757 34 12843
2011-09-26 4 FORM 4 0001140361-11-046974 6112
2011-09-22 4 FORM 4 0001140361-11-046727 6113
2011-09-22 8-K NANOVIRCIDES INC 8-K 9-16-2011 1.01,3.02 0001140361-11-046698 000-52318 111103213 34 25872
2011-09-20 4 FORM 4 0001140361-11-046483 6114
2011-09-16 4 FORM 4 0001140361-11-046215 6113
2011-09-14 4 FORM 4 0001140361-11-045875 6113
2011-09-12 4 FORM 4 0001140361-11-045540 4651
2011-09-12 4/A FORM 4/A 0001140361-11-045448 6464
2011-09-09 4 FORM 4 0001140361-11-045364 6111
2011-09-06 4 FORM 4 0001140361-11-044834 6114
2011-09-01 4 FORM 4 0001140361-11-044457 6116
2011-08-31 4 FORM 4 0001140361-11-044264 6113
2011-08-26 4 FORM 4 0001140361-11-043816 6114
2011-08-24 4 FORM 4 0001140361-11-043582 6113
2011-08-22 4 FORM 4 0001140361-11-043220 6113
2011-08-18 4 FORM 4 0001140361-11-042785 7576
2011-08-15 4 FORM 4 0001140361-11-042152 6113
2011-08-11 4 FORM 4 0001140361-11-041266 7577
2011-08-09 4 FORM 4 0001140361-11-040737 6114
2011-08-05 4 FORM 4 0001140361-11-039775 4651
2011-08-02 4 FORM 4 0001140361-11-039143 6112
2011-07-27 4 FORM 4 0001140361-11-038213 6113
2011-07-27 8-K NANOVIRICIDES, INC. 8-K 7-26-2011 8.01,9.01 0001140361-11-038166 000-52318 11990368 34 48358
2011-07-26 424B3 NANOVIRICIDES INC 424B3 7-26-2011 0001140361-11-037960 333-165221 11985995 33 19497
2011-07-25 4 FORM 4 0001140361-11-037915 6111
2011-07-21 4 FORM 4 0001140361-11-037620 7574
2011-07-18 4 FORM 4 0001140361-11-037194 6112
2011-07-14 4 FORM 4 0001140361-11-036860 6111
2011-07-13 4 FORM 4 0001140361-11-036671 6112
2011-07-08 4 FORM 4 0001140361-11-036288 6113
2011-07-06 4 FORM 4 0001140361-11-035963 6112

Latest XBRL company facts

One latest value per concept from companyfacts (312 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 25.55M 2026-11-14 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
dei EntityPublicFloat Entity Public Float USD 23.69M 2025-12-31 2026 FY 10-K 2026-09-28 0001104659-26-111390
ffd NetFeeAmt NetFeeAmt USD 608.14 2026-08-21 S-3 2026-08-21 0001104659-26-099705
ffd TtlFeeAmt TtlFeeAmt USD 608.14 2026-08-21 S-3 2026-08-21 0001104659-26-099705
ffd TtlOfferingAmt TtlOfferingAmt USD 4.40M 2026-08-21 S-3 2026-08-21 0001104659-26-099705
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-21 S-3 2026-08-21 0001104659-26-099705
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-08-21 S-3 2026-08-21 0001104659-26-099705
invest InvestmentWarrantsExercisePrice Investment Warrants, Exercise Price USD 3.5 2013-02-01 2013-06-30 2015 Q3 10-Q 2015-05-15 0001144204-15-031364
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 243,881 2023-03-31 2023 Q3 10-Q 2023-05-15 0001410578-23-001235
us-gaap AccountsPayableRelatedPartiesCurrentAndNoncurrent Accounts Payable, Related Parties USD 53,160 2021-12-31 2021 Q2 10-Q 2022-02-14 0001410578-22-000141
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 62,695 2023-03-31 2023 Q3 10-Q 2023-05-15 0001410578-23-001235
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 38,331 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 2,500 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap AccruedRoyaltiesCurrentAndNoncurrent Accrued Royalties USD 0 2022-03-31 2022 Q3 10-Q 2022-05-16 0001410578-22-001688
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 24,228 2021-03-31 2021 Q3 10-Q 2021-05-14 0001104659-21-066909
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 8.43M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 169.22M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap AdjustmentForAmortization Amortization USD 6,202 2021-07-01 2022-03-31 2022 Q3 10-Q 2022-05-16 0001410578-22-001688
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD 139 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 83,900 2013-07-01 2014-06-30 2016 FY 10-K 2016-09-16 0001144204-16-124276
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 8,125 2023-07-01 2024-03-31 2024 Q3 10-Q 2024-05-15 0001410578-24-000843
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 11,920 2018-07-01 2019-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 427,500 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 53,500 2017-07-01 2018-06-30 2020 FY 10-K 2020-10-13 0001104659-20-114577
us-gaap AdvancesToAffiliate Advances to Affiliate USD 1.00M 2013-03-31 2013 Q3 10-Q/A 2013-05-20 0001144204-13-030526
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 563 2023-07-01 2024-06-30 2024 FY 10-K 2024-09-27 0001410578-24-001650
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 241,560 2014-07-01 2014-12-31 2015 Q2 10-Q 2015-02-25 0001144204-15-011875
us-gaap AmortizationOfDeferredCharges Amortization of Deferred Charges USD 0 2013-07-01 2013-09-30 2015 Q1 10-Q 2014-11-14 0001144204-14-068843
us-gaap AmortizationOfDeferredLoanOriginationFeesNet Amortization of Deferred Loan Origination Fees, Net USD -1,638 2019-07-01 2019-12-31 2020 Q2 10-Q 2020-02-14 0001104659-20-021930
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 0 2018-07-01 2019-06-30 2020 FY 10-K 2020-10-13 0001104659-20-114577
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 2,068 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 11.00M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap Assets Assets USD 9.56M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap AssetsCurrent Assets, Current USD 2.98M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap BridgeLoan Bridge Loan USD 1.00M 2019-09-30 2020 Q1 10-Q 2019-11-15 0001104659-19-064800
us-gaap BusinessAcquisitionPercentageOfVotingInterestsAcquired Business Acquisition, Percentage of Voting Interests Acquired pure 0.8 2012-12-31 2013 Q2 10-Q/A 2013-02-22 0001144204-13-010726
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 2.58M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -999,406 2018-07-01 2018-09-30 2019 Q1 10-Q 2018-11-14 0001144204-18-059983
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 2.58M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -218,883 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap CashCollateralForBorrowedSecurities Cash Collateral for Borrowed Securities USD 1.00M 2013-02-11 2015 Q1 10-Q/A 2015-02-23 0001144204-15-011471
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 3 2020-01-27 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 347,222 2020-01-27 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 0 2019-03-31 2019 Q3 10-Q 2019-05-15 0001144204-19-026612
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 150.00M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 25.55M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 25.55M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap CommonStockValue Common Stock, Value, Issued USD 255 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 1.15M 2019-07-01 2020-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap ConvertiblePreferredStockSharesIssuedUponConversion Convertible Preferred Stock, Shares Issued upon Conversion shares 3.5 2020-03-31 2020 Q3 10-Q 2020-06-22 0001104659-20-075651
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 1.50M 2023-07-01 2024-06-30 2025 FY 10-K 2025-09-29 0001104659-25-094527
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 7,500 2017-11-01 2017-11-13 2020 FY 10-K 2020-10-13 0001104659-20-114577
us-gaap DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 Debt Conversion, Converted Instrument, Warrants or Options Issued shares 571,433 2016-02-02 2016-02-29 2016 FY 10-K 2016-09-16 0001144204-16-124276
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 5.33M 2017-01-15 2017-02-08 2019 FY 10-K 2019-08-23 0001144204-19-041547
us-gaap DebtInstrumentAnnualPrincipalPayment Debt Instrument, Annual Principal Payment USD 2.00M 2013-02-11 2015 Q1 10-Q/A 2015-02-23 0001144204-15-011471
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 0 2013-07-01 2013-12-31 2015 Q2 10-Q 2015-02-25 0001144204-15-011875
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 3.5 2013-02-01 2014 FY 10-K 2015-02-23 0001144204-15-011466
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 234,198 2022-01-01 2023 FY 10-K 2023-10-13 0001410578-23-002146
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.08 2013-06-30 2014 FY 10-K 2015-02-23 0001144204-15-011466
us-gaap DebtInstrumentInterestRateIncreaseDecrease Debt Instrument, Interest Rate, Increase (Decrease) pure 0.07 2013-07-01 2014-06-30 2015 Q2 10-Q 2015-02-25 0001144204-15-011875
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.047 2022-01-01 2023 FY 10-K 2023-10-13 0001410578-23-002146
us-gaap DebtInstrumentPeriodicPayment Debt Instrument, Periodic Payment USD 23,932 2022-01-01 2023 FY 10-K 2023-10-13 0001410578-23-002146
us-gaap DebtInstrumentRedemptionPricePercentage Debt Instrument, Redemption Price, Percentage pure 0 2014-07-01 2014-09-30 2015 Q1 10-Q/A 2015-02-23 0001144204-15-011471
us-gaap DebtInstrumentRedemptionPricePercentageOfPrincipalAmountRedeemed Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed pure 0 2014-07-01 2014-09-30 2015 Q1 10-Q/A 2015-02-23 0001144204-15-011471
us-gaap DeferredCompensationArrangementWithIndividualCompensationExpense Deferred Compensation Arrangement with Individual, Compensation Expense USD 400,000 2019-07-01 2020-06-30 2020 FY 10-K 2020-10-13 0001104659-20-114577
us-gaap DeferredCompensationArrangementWithIndividualSharesAuthorizedForIssuance Deferred Compensation Arrangement with Individual, Shares Authorized for Issuance shares 26,250 2021-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap DeferredCostsAndOtherAssets Deferred Costs and Other Assets USD 12,190 2020-06-30 2021 Q3 10-Q 2021-05-14 0001104659-21-066909
us-gaap DeferredFinanceCostsCurrentNet Debt Issuance Costs, Current, Net USD 37,408 2022-03-31 2022 Q3 10-Q 2022-05-16 0001410578-22-001688
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 12,190 2020-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 43.52M 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 32.21M 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 11,412 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 8.12M 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Loss Reserves USD 33.24M 2014-06-30 2014 FY 10-K 2015-02-23 0001144204-15-011466
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 43.52M 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap Depletion Depletion USD 203,234 2013-07-01 2014-06-30 2014 FY 10-K 2015-02-23 0001144204-15-011466
us-gaap Depreciation Depreciation USD 126,123 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap DerivativeFairValueOfDerivativeNet Derivative, Fair Value, Net USD 5.70M 2014-06-30 2014 FY 10-K 2015-02-23 0001144204-15-011466
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD -5.85M 2019-07-01 2020-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap DerivativeLiabilities Derivative Liability USD 1.15M 2020-03-23 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 0 2019-03-31 2019 Q3 10-Q 2019-05-15 0001144204-19-026612
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 1.59M 2019-03-31 2019 Q3 10-Q 2019-05-15 0001144204-19-026612
us-gaap DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) USD 51.90M 2014-06-30 2014 FY 10-K 2015-02-23 0001144204-15-011466
us-gaap DilutiveSecuritiesEffectOnBasicEarningsPerShareOther Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities USD 0 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-28 0001144204-17-050412
us-gaap DueToOfficersOrStockholdersCurrent Due to Officers or Stockholders, Current USD 0 2021-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 0 2012-06-30 2012 FY 10-K/A 2012-10-26 0001144204-12-058049
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 5.00M 2017-06-30 2017 FY 10-K 2017-09-28 0001144204-17-050412
us-gaap DueToRelatedPartiesNoncurrent Due to Related Parties, Noncurrent USD 4.73M 2018-03-31 2018 Q3 10-Q 2018-05-21 0001144204-18-030083
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.23 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.81 2020-07-01 2021-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.23 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.098 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2020-07-01 2021-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure 0 2024-07-01 2025-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent pure -0.053 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.005 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure 0 2022-07-01 2023-06-30 2023 FY 10-K 2023-10-13 0001410578-23-002146
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure -0.072 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.019 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap EmbeddedDerivativeLossOnEmbeddedDerivative Embedded Derivative, Loss on Embedded Derivative USD 1.88M 2014-07-01 2014-09-30 2015 Q1 10-Q/A 2015-02-23 0001144204-15-011471
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 122,555 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-21 0001144204-18-030083
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 25,862 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 23,841 2018-09-30 2019 Q1 10-Q 2018-11-14 0001144204-18-059983
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 0 2022-06-30 2022 FY 10-K 2022-10-13 0001410578-22-002878
us-gaap EquityMethodInvestmentOwnershipPercentage Equity Method Investment, Ownership Percentage pure 0.7 2014-03-31 2014 Q3 10-Q 2014-05-15 0001144204-14-031119
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 5.72M 2020-01-27 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.219 2014-07-01 2014-09-30 2015 Q1 10-Q/A 2015-02-23 0001144204-15-011471
us-gaap FairValueAssumptionsWeightedAverageVolatilityRate Fair Value Assumptions, Weighted Average Volatility Rate (Deprecated 2018-01-31) pure 0.75 2014-01-23 2014-12-31 2014 FY 10-K 2015-02-23 0001144204-15-011466
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3 Fair Value, Measurement with Unobservable Inputs Reconciliation, Liability, Transfers out of Level 3 USD 0 2013-07-01 2014-06-30 2014 FY 10-K 2015-02-23 0001144204-15-011466
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings USD 1.44M 2013-07-01 2014-06-30 2014 FY 10-K 2015-02-23 0001144204-15-011466
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) USD 0 2019-07-01 2020-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchases Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases USD 0 2019-07-01 2020-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements) USD 5.90M 2013-07-01 2014-06-30 2014 FY 10-K 2015-02-23 0001144204-15-011466
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD 0 2019-07-01 2020-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 0 2020-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss) USD 819,994 2017-07-01 2018-06-30 2020 FY 10-K 2020-10-13 0001104659-20-114577
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 152,253 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive Finite-Lived Intangible Asset, Expected Amortization, after Year Five USD 300,493 2022-06-30 2022 FY 10-K 2022-10-13 0001410578-22-002878
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths Finite-Lived Intangible Asset, Expected Amortization, Year One USD 8,271 2022-06-30 2022 FY 10-K 2022-10-13 0001410578-22-002878
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFive Finite-Lived Intangible Asset, Expected Amortization, Year Five USD 8,271 2022-06-30 2022 FY 10-K 2022-10-13 0001410578-22-002878
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearFour Finite-Lived Intangible Asset, Expected Amortization, Year Four USD 8,271 2022-06-30 2022 FY 10-K 2022-10-13 0001410578-22-002878
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearThree Finite-Lived Intangible Asset, Expected Amortization, Year Three USD 8,271 2022-06-30 2022 FY 10-K 2022-10-13 0001410578-22-002878
us-gaap FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo Finite-Lived Intangible Asset, Expected Amortization, Year Two USD 8,271 2022-06-30 2022 FY 10-K 2022-10-13 0001410578-22-002878
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 153,393 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 1,140 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap FixturesAndEquipmentGross Fixtures and Equipment, Gross USD 6.11M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap FurnitureAndFixturesGross Furniture and Fixtures, Gross USD 5,607 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2018-07-01 2019-06-30 2020 FY 10-K 2020-10-13 0001104659-20-114577
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 1.07M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -8.22M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap IncomeLossFromContinuingOperationsPerBasicShare Income (Loss) from Continuing Operations, Per Basic Share USD/shares -0.13 2017-07-01 2018-06-30 2018 FY 10-K 2018-10-12 0001144204-18-053665
us-gaap IncomeLossFromContinuingOperationsPerDilutedShare Income (Loss) from Continuing Operations, Per Diluted Share USD/shares -0.17 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-28 0001144204-17-050412
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2022-07-01 2023-06-30 2023 FY 10-K 2023-10-13 0001410578-23-002146
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2021-07-01 2021-12-31 2021 Q2 10-Q 2022-02-14 0001410578-22-000141
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 0 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 805,734 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -1.73M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 437,639 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 42,686 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 592,729 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 152,901 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD -124,136 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 203,841 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap IncreaseDecreaseInDeferredCharges Increase (Decrease) in Deferred Charges USD 0 2015-07-01 2016-03-31 2016 Q3 10-Q 2016-05-10 0001144204-16-100445
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD 0 2005-05-12 2012-06-30 2012 FY 10-K/A 2012-10-26 0001144204-12-058049
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 40,145 2013-07-01 2013-12-31 2015 Q2 10-Q 2015-02-25 0001144204-15-011875
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD 0 2013-07-01 2013-09-30 2015 Q1 10-Q 2014-11-14 0001144204-14-068843
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 0 2018-07-01 2019-06-30 2020 FY 10-K 2020-10-13 0001104659-20-114577
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 12,362 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 0 2015-07-01 2016-03-31 2016 Q3 10-Q 2016-05-10 0001144204-16-100445
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -357 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap IncreaseDecreaseInOtherOperatingAssets Increase (Decrease) in Other Operating Assets USD -37,752 2016-07-01 2017-03-31 2017 Q3 10-Q 2017-05-15 0001144204-17-027501
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 36,534 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD 370,187 2016-07-01 2017-03-31 2017 Q3 10-Q 2017-05-15 0001144204-17-027501
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD 0 2017-07-01 2018-06-30 2018 FY 10-K 2018-10-12 0001144204-18-053665
us-gaap IncrementalCommonSharesAttributableToConversionOfDebtSecurities Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities shares 0 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-28 0001144204-17-050412
us-gaap IndefiniteLivedIntangibleAssetsExcludingGoodwill Indefinite-lived Intangible Assets (Excluding Goodwill) USD 305,561 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap IntangibleAssetsGrossExcludingGoodwill Intangible Assets, Gross (Excluding Goodwill) USD 458,954 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 306,701 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap InterestExpense Interest Expense USD 49,808 2023-07-01 2024-03-31 2024 Q3 10-Q 2024-05-15 0001410578-24-000843
us-gaap InterestExpenseDebt Interest Expense, Debt USD 49,808 2023-07-01 2024-06-30 2025 FY 10-K 2025-09-29 0001104659-25-094527
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 149 2024-07-01 2025-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD 73,133 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-21 0001144204-18-030083
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 173,589 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-28 0001144204-17-050412
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 149 2024-07-01 2025-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2018-06-30 2018 FY 10-K 2018-10-12 0001144204-18-053665
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 375,000 2016-03-31 2016 Q3 10-Q 2016-05-10 0001144204-16-100445
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 25,553 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 38,250 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap Land Land USD 260,000 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap LandSubjectToGroundLeases Land Subject to Ground Leases acre 18,000 2013-02-11 2014 Q1 10-Q/A 2013-11-18 0001144204-13-062836
us-gaap LeaseholdImprovementsGross Leasehold Improvements, Gross USD 8.25M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap LegalFees Legal Fees USD 7.46M 2020-01-25 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap Liabilities Liabilities USD 3.20M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 9.56M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap LiabilitiesCurrent Liabilities, Current USD 3.15M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 1.46M 2017-09-30 2018 Q1 10-Q 2017-11-14 0001144204-17-059130
us-gaap LifeInsuranceCorporateOrBankOwnedAmount Life Insurance, Corporate or Bank Owned, Amount USD 2.00M 2018-07-11 2018 FY 10-K 2018-10-12 0001144204-18-053665
us-gaap LineOfCreditFacilityCurrentBorrowingCapacity Line of Credit Facility, Current Borrowing Capacity USD 3.00M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap LinesOfCreditCurrent Line of Credit, Current USD 2.00M 2024-03-31 2024 Q3 10-Q 2024-05-15 0001410578-24-000843
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 150,000 2014-07-01 2014-12-31 2015 Q2 10-Q 2015-02-25 0001144204-15-011875
us-gaap LoanProcessingFee Loan Processing Fee USD 39,301 2019-07-01 2020-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap LoansPayable Loans Payable USD 94,788 2022-06-30 2023 FY 10-K 2023-10-13 0001410578-23-002146
us-gaap LongTermDebtCurrent Long-term Debt, Current Maturities USD 0 2017-03-31 2017 Q3 10-Q 2017-05-15 0001144204-17-027501
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 4.73M 2018-03-21 2020 FY 10-K 2020-10-13 0001104659-20-114577
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 1.50M 2023-09-30 2024 Q1 10-Q 2023-11-14 0001410578-23-002484
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 3.42M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD -1.00M 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-28 0001144204-17-050412
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -84,317 2025-07-01 2025-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -164,978 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-28 0001144204-17-050412
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -3.64M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -7.90M 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-28 0001144204-17-050412
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -5.74M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -8.56M 2017-07-01 2018-06-30 2018 FY 10-K 2018-10-12 0001144204-18-053665
us-gaap NetIncomeLossAvailableToCommonStockholdersDiluted Net Income (Loss) Available to Common Stockholders, Diluted USD -10.30M 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-28 0001144204-17-050412
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 25,553 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap OperatingExpenses Operating Expenses USD 5.77M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -5.77M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 0 2015-07-01 2016-03-31 2016 Q3 10-Q 2016-05-10 0001144204-16-100445
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 119.90M 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 31,000 2018-12-31 2019 Q2 10-Q 2019-02-14 0001144204-19-008138
us-gaap OtherAssets Other Assets USD 14,361 2023-06-30 2023 FY 10-K 2023-10-13 0001410578-23-002146
us-gaap OtherAssetsCurrent Other Assets, Current USD 0 2015-06-30 2015 FY 10-K 2015-09-14 0001144204-15-054864
us-gaap OtherDepreciationAndAmortization Other Depreciation and Amortization USD 804,107 2005-05-12 2012-03-31 2012 Q3 10-Q 2012-05-21 0001144204-12-030837
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 2,000 2021-07-01 2022-03-31 2022 Q3 10-Q 2022-05-16 0001410578-22-001688
us-gaap OtherLongTermNotesPayable Other Notes Payable, Noncurrent USD 1.50M 2023-06-30 2024 FY 10-K 2024-09-27 0001410578-24-001650
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 87,852 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap OtherOperatingIncome Other Operating Income USD -8.67M 2013-07-01 2014-06-30 2014 FY 10-K 2015-02-23 0001144204-15-011466
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 370,187 2017-03-31 2017 Q3 10-Q 2017-05-15 0001144204-17-027501
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 501,378 2017-07-01 2018-03-31 2019 Q3 10-Q 2019-05-15 0001144204-19-026612
us-gaap PaymentsForAdvanceToAffiliate Payments for Advance to Affiliate USD -1.00M 2014-07-01 2015-06-30 2015 FY 10-K 2015-09-14 0001144204-15-054864
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 37,408 2021-07-01 2022-03-31 2023 Q3 10-Q 2023-05-15 0001410578-23-001235
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.06M 2020-07-10 2021 Q2 10-Q 2021-02-16 0001104659-21-024154
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 0 2014-07-01 2014-09-30 2015 Q1 10-Q/A 2015-02-23 0001144204-15-011471
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 84,317 2025-07-01 2025-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0.06 2011-03-01 2011-03-31 2014 FY 10-K 2015-02-23 0001144204-15-011466
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2019-03-31 2019 Q3 10-Q 2019-05-15 0001144204-19-026612
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 8.50M 2019-03-31 2019 Q3 10-Q 2019-05-15 0001144204-19-026612
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 5.11M 2019-03-31 2019 Q3 10-Q 2019-05-15 0001144204-19-026612
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 5.11M 2019-03-31 2019 Q3 10-Q 2019-05-15 0001144204-19-026612
us-gaap PreferredUnitsOfferingCosts Preferred Units, Offering Costs USD 200,000 2012-12-31 2013 Q2 10-Q/A 2013-02-22 0001144204-13-010726
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 405,047 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 483,501 2014-09-30 2015 Q1 10-Q/A 2015-02-23 0001144204-15-011471
us-gaap PrepaidInterest Prepaid Interest USD 29,040 2020-12-31 2021 Q2 10-Q 2021-02-16 0001104659-21-024154
us-gaap ProceedsFromCollectionOfAdvanceToAffiliate Proceeds from Collection of Advance to Affiliate USD 0 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-28 0001144204-17-050412
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2015-07-01 2016-06-30 2016 FY 10-K 2016-09-16 0001144204-16-124276
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 2.35M 2019-02-01 2019-02-27 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 1.91M 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 510,963 2012-07-01 2013-06-30 2015 FY 10-K 2015-09-14 0001144204-15-054864
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 9.20M 2020-05-22 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 5.74M 2015-07-01 2016-06-30 2016 FY 10-K 2016-09-16 0001144204-16-124276
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 21,965 2025-10-01 2025-12-31 2026 Q3 10-Q 2026-05-15 0001104659-26-061499
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 1.10M 2019-07-01 2020-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2013-07-01 2014-06-30 2014 FY 10-K 2015-02-23 0001144204-15-011466
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-28 0001144204-17-050412
us-gaap ProfessionalFees Professional Fees USD 125,000 2019-02-27 2019 FY 10-K 2019-08-23 0001144204-19-041547
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -5.74M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap PropertyPlantAndEquipmentDisposals Property, Plant and Equipment, Disposals USD 0 2017-07-01 2018-06-30 2018 FY 10-K 2018-10-12 0001144204-18-053665
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 14.70M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 6.28M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 0 2018-07-01 2019-06-30 2019 FY 10-K 2019-08-23 0001144204-19-041547
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 4.70M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap RestrictedStockExpense Restricted Stock or Unit Expense USD 43,956 2018-07-01 2019-03-31 2019 Q3 10-Q 2019-05-15 0001144204-19-026612
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -162.80M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 0 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap SalariesAndWages Salary and Wage, NonOfficer, Excluding Cost of Good and Service Sold USD 58,910 2015-07-01 2016-06-30 2016 FY 10-K 2016-09-16 0001144204-16-124276
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 7.3 2020-05-21 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 0 2005-05-12 2012-03-31 2012 Q3 10-Q 2012-05-21 0001144204-12-030837
us-gaap SecuritiesSegregatedUnderSecuritiesExchangeCommissionRegulation Securities Segregated under Securities Exchange Commission Regulation USD 40.00M 2012-10-26 2013 Q1 10-Q 2012-11-19 0001144204-12-063924
us-gaap SecurityDeposit Security Deposit USD 3,515 2022-06-30 2023 FY 10-K 2023-10-13 0001410578-23-002146
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 35,761 2018-07-01 2019-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 2,551 2023-07-01 2024-03-31 2024 Q3 10-Q 2024-05-15 0001410578-24-000843
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2015-07-01 2015-12-31 2016 Q2 10-Q 2016-02-09 0001144204-16-079966
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.551 2018-07-01 2018-09-30 2019 Q1 10-Q 2018-11-14 0001144204-18-059983
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.551 2018-07-01 2018-12-31 2019 Q2 10-Q 2019-02-14 0001144204-19-008138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.498 2018-07-01 2018-12-31 2019 Q2 10-Q 2019-02-14 0001144204-19-008138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.027 2018-07-01 2018-09-30 2019 Q1 10-Q 2018-11-14 0001144204-18-059983
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.029 2018-07-01 2018-12-31 2019 Q2 10-Q 2019-02-14 0001144204-19-008138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.02 2018-07-01 2019-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Exercised shares 35,357 2013-07-01 2014-06-30 2014 FY 10-K 2015-02-23 0001144204-15-011466
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized shares 71,430 2019-03-31 2019 Q3 10-Q 2019-05-15 0001144204-19-026612
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 0 2015-07-01 2016-03-31 2016 Q3 10-Q 2016-05-10 0001144204-16-100445
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 15,000 2018-07-19 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Number of Shares shares 10,000 2019-01-24 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2018-06-30 2019 Q2 10-Q 2019-02-14 0001144204-19-008138
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 0.1 2014-06-30 2015 Q2 10-Q 2015-02-25 0001144204-15-011875
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 35,761 2018-09-30 2019 Q1 10-Q 2018-11-14 0001144204-18-059983
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 35,761 2018-07-01 2018-09-30 2019 Q1 10-Q 2018-11-14 0001144204-18-059983
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 0 2020-07-01 2021-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent Share-based Compensation Arrangement by Share-based Payment Award, Purchase Price of Common Stock, Percent pure 0.2 2018-07-19 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period shares 10,000 2019-07-01 2020-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 0.5 2018-07-01 2019-03-31 2019 Q3 10-Q 2019-05-15 0001144204-19-026612
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.5 2018-07-01 2019-03-31 2019 Q3 10-Q 2019-05-15 0001144204-19-026612
us-gaap SharePrice Share Price USD/shares 4.8 2019-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 6.41M 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 20 2019-09-24 2020 FY 10-K 2020-10-13 0001104659-20-114577
us-gaap StockIssued1 Stock Issued USD 146,850 2025-07-01 2025-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 71,429 2014-04-01 2014-06-30 2014 FY 10-K 2015-02-23 0001144204-15-011466
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 2.52M 2026-07-27 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensationGross Shares Issued, Shares, Share-based Payment Arrangement, before Forfeiture shares 507,649 2015-07-01 2016-06-30 2017 FY 10-K 2017-09-28 0001144204-17-050412
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2015-07-01 2016-03-31 2016 Q3 10-Q 2016-05-10 0001144204-16-100445
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 0 2005-05-12 2005-06-30 2014 Q3 10-Q 2014-05-15 0001144204-14-031119
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 5.33M 2016-07-01 2017-06-30 2019 FY 10-K 2019-08-23 0001144204-19-041547
us-gaap StockIssuedDuringPeriodValueEmployeeBenefitPlan Stock Issued During Period, Value, Employee Benefit Plan USD 1,731 2025-07-01 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 297,860 2014-04-01 2014-06-30 2014 FY 10-K 2015-02-23 0001144204-15-011466
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 3.42M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 3,300 2015-07-01 2016-03-31 2016 Q3 10-Q 2016-05-10 0001144204-16-100445
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 2.01M 2015-07-01 2016-06-30 2017 FY 10-K 2017-09-28 0001144204-17-050412
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 0 2015-07-01 2016-06-30 2018 FY 10-K 2018-10-12 0001144204-18-053665
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 0 2019-07-01 2020-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased Stock Repurchase Program, Number of Shares Authorized to be Repurchased shares 1.40M 2020-05-21 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap TaxesPayableCurrent Taxes Payable, Current USD 25,100 2020-09-30 2020 Q1 10-Q 2020-11-16 0001104659-20-125844
us-gaap UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic Undistributed Earnings (Loss) Allocated to Participating Securities, Basic USD 0 2025-07-01 2026-03-31 2026 Q3 10-Q 2026-05-15 0001104659-26-061499
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-06-30 2026 FY 10-K 2026-09-28 0001104659-26-111390
us-gaap UnrecognizedTaxBenefitsInterestOnIncomeTaxesExpense Unrecognized Tax Benefits, Interest on Income Taxes Expense USD 0 2022-07-01 2023-06-30 2023 FY 10-K 2023-10-13 0001410578-23-002146
us-gaap UnsecuredDebt Unsecured Debt USD 6.00M 2013-06-30 2014 FY 10-K 2015-02-23 0001144204-15-011466
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 6.07M 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-28 0001144204-17-050412
us-gaap WarrantsNotSettleableInCashFairValueDisclosure Warrants Not Settleable in Cash, Fair Value Disclosure USD 1.53M 2019-02-27 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 24.79M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 10.90M 2020-07-01 2021-06-30 2021 FY 10-K 2021-10-12 0001104659-21-125343
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 24.79M 2026-07-01 2026-09-30 2027 Q1 10-Q 2026-11-16 0001104659-26-128532

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →